Insider · CIK 0001502240

OrbiMed Capital GP IV LLC

CIK 0001502240 Name as filed on the most recent filing

Filed as OrbiMed Capital GP IV LLC (55)

195 transaction lines · from 55 filings · filed 2010-10-04 to 2024-07-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2019-08-07 S, Open-market sale Alector, Inc.ALEC 2 lines 11,635,000, disposed Open Form 4 filing 0000947871-19-000576
2019-05-21 S, Open-market sale Principia Biopharma Inc.PRNB 30,250,000, disposed Open Form 4 filing 0000947871-19-000395
2019-02-11 P, Open-market purchase Alector, Inc.ALEC 3 lines 7,822,300, acquired Open Form 4 filing 0001209191-19-009118
2018-09-18 P, Open-market purchase Principia Biopharma Inc.PRNB 4,250,000, acquired Open Form 4 filing 0001209191-18-051836
2018-03-12 S, Open-market sale Audentes Therapeutics, Inc.BOLD 2 lines 629,859, disposed Open Form 4 filing 0000947871-18-000243
2018-03-09 S, Open-market sale Audentes Therapeutics, Inc.BOLD 3 lines 2,850,010, disposed Open Form 4 filing 0000947871-18-000243
2018-03-08 S, Open-market sale Audentes Therapeutics, Inc.BOLD 1,990,058, disposed Open Form 4 filing 0000947871-18-000243
2018-03-06 S, Open-market sale Audentes Therapeutics, Inc.BOLD 375,617, disposed Open Form 4 filing 0000947871-18-000219
2018-03-05 S, Open-market sale Audentes Therapeutics, Inc.BOLD 7,212, disposed Open Form 4 filing 0000947871-18-000219
2018-03-02 S, Open-market sale Audentes Therapeutics, Inc.BOLD 2 lines 14,827,787, disposed Open Form 4 filing 0000947871-18-000219
2017-09-29 S, Open-market sale Audentes Therapeutics, Inc.BOLD 18,984,000, disposed Open Form 4 filing 0000947871-17-000769
2017-09-07 S, Open-market sale Audentes Therapeutics, Inc.BOLD 111,750, disposed Open Form 4 filing 0000947871-17-000705
2016-07-25 S, Open-market sale Relypsa IncRLYP 10,988,328, disposed Open Form 4 filing 0000947871-16-001364
2016-07-22 S, Open-market sale Relypsa IncRLYP 118,400,000, disposed Open Form 4 filing 0000947871-16-001364
2015-12-23 S, Open-market sale Relypsa IncRLYP 2 lines 2,717,564, disposed Open Form 4 filing 0000947871-15-000885
2015-12-22 S, Open-market sale Relypsa IncRLYP 2 lines 3,982,837, disposed Open Form 4 filing 0000947871-15-000885
2015-12-21 S, Open-market sale Relypsa IncRLYP 2 lines 6,887,612, disposed Open Form 4 filing 0000947871-15-000885
2015-11-30 S, Open-market sale Otonomy, Inc.OTIC 2 lines 95,026, disposed Open Form 4 filing 0000947871-15-000861
2015-11-27 S, Open-market sale Otonomy, Inc.OTIC 840,130, disposed Open Form 4 filing 0000947871-15-000861
2015-11-25 S, Open-market sale Otonomy, Inc.OTIC 1,006,068, disposed Open Form 4 filing 0000947871-15-000861
2015-11-24 S, Open-market sale Otonomy, Inc.OTIC 1,037,875, disposed Open Form 4 filing 0000947871-15-000852
2015-11-23 S, Open-market sale Otonomy, Inc.OTIC 2,298,760, disposed Open Form 4 filing 0000947871-15-000852
2015-11-20 S, Open-market sale Otonomy, Inc.OTIC 2,398,701, disposed Open Form 4 filing 0000947871-15-000852
2015-11-19 S, Open-market sale Otonomy, Inc.OTIC 3,640,780, disposed Open Form 4 filing 0000947871-15-000845
2015-11-17 S, Open-market sale Otonomy, Inc.OTIC 2 lines 319,680, disposed Open Form 4 filing 0000947871-15-000845
2015-10-22 P, Open-market purchase Relypsa IncRLYP 2 lines 6,280,165, acquired Open Form 4 filing 0000947871-15-000752
2015-05-18 S, Open-market sale Relypsa IncRLYP 49,746,216, disposed Open Form 4 filing 0000947871-15-000406
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 7,498,927, disposed Open Form 4 filing 0000947871-15-000264
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 6,816,658, disposed Open Form 4 filing 0000947871-15-000264
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 5,180,654, disposed Open Form 4 filing 0000947871-15-000264
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 4,787,349, disposed Open Form 4 filing 0000947871-15-000264
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 4,373,918, disposed Open Form 4 filing 0000947871-15-000264
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 4,052,739, disposed Open Form 4 filing 0000947871-15-000264
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 2,646,815, disposed Open Form 4 filing 0000947871-15-000264
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 2,369,046, disposed Open Form 4 filing 0000947871-15-000264
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 2,178,573, disposed Open Form 4 filing 0000947871-15-000264
2015-03-26 S, Open-market sale Intercept Pharmaceuticals IncICPT 1,752,780, disposed Open Form 4 filing 0000947871-15-000264

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. OrbiMed Capital GP IV LLC, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001502240

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.